NASHVILLE, TENNESSEE
2024
Other Health Care
2
$25.91M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-10-19 | New offering first sale 2026-10-01 | $10.91M | $17.50M | details · SEC filing |
| 2024-12-30 | New offering first sale 2024-12-20 | $15M | $15M | SEC filing |
What do you want to do with MODEL ONCOLOGY, LLC?
Who to contact
- Thomas Harper, Jr. — Executive Officer, Promoter
- David Chernow — Executive Officer, Director
- Robert Ortenzio — Director
- Martin Jackson — Director
- William Downey — Director
- Stanley Marks, Md — Director
- Max Buetow — Director
- Phillip Watts — Mr. Watts is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years.
- Steven Cutler — Mr. Cutler is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years.
- Round: Form D filed 2026-10-19
- Amount sold: $10.91M
- Industry: Other Health Care
- Founded: 2024
- Based: NASHVILLE, TENNESSEE
People listed
- Thomas Harper, Jr. — Executive Officer, Promoter
- David Chernow — Executive Officer, Director
- Robert Ortenzio — Director
- Martin Jackson — Director
- William Downey — Director
- Stanley Marks, Md — Director
- Max Buetow — Director
- Phillip Watts — Mr. Watts is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years.
- Steven Cutler — Mr. Cutler is no longer affiliated with the Issuer, but has served as a promoter within the past 5 years.
- Filing: Form D filed 2026-10-19
- Amount sold: $10.91M
- Industry group: Other Health Care
- Year formed: 2024
- Based: NASHVILLE, TENNESSEE
- Entity type: Limited Liability Company
We'll show it in your MentionFox inbox when MODEL ONCOLOGY, LLC raises, hires or launches. No email unless you switch it on.
Watch MODEL ONCOLOGY, LLC →Want the whole picture on MODEL ONCOLOGY, LLC?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on MODEL ONCOLOGY, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MODEL ONCOLOGY, LLC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from MODEL ONCOLOGY, LLC's own filings with the SEC. The people those filings name are on the team page.